Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Keros Therapeutics Commences Issuer Tender Offer to Repurchase up to $194.4 Million Shares
-
The Ensign Group Schedules Third Quarter Earnings Call for Tuesday, November 4, 2025
-
GEN Korean BBQ Expands from 31 to 300 Grocery Stores Amid Rising Demand
-
Titan Mining Finds Significant Concentrations of Germanium at its Empire State Mine in New York
-
RadNet, Inc. Announces Date of its Third Quarter 2025 Financial Results Conference Call
-
GEN Korean BBQ Expands from 31 to 300 Grocery Stores Amid Rising Demand
-
Path Forward Statement on the Case for Greater Employer Visibility into Mental Health Benefits
-
Biodesix to Report Third Quarter 2025 Financial Results on November 3, 2025
-
Transactions in connection with share buyback programme
-
Ypay Launches New Crypto Payroll Platform at Expand North Star 2025
-
Brothers, 19 and 20, Stanford dropouts, raise $4.1M in oversubscribed seed round to build Golpo AI and reimagine AI video generation
-
HighPeak Energy, Inc. Announces 2025 Third Quarter Earnings Release and Conference Call Dates
-
Form 8.5 (EPT/RI) - Greencore Group Plc
-
A Gastronomic Extravaganza: World-Renowned Chefs and Fine Wines Unite at Hong Kong Wine & Dine Festival 2025
-
A Gastronomic Extravaganza: World-Renowned Chefs and Fine Wines Unite at Hong Kong Wine & Dine Festival 2025
-
Director Declaration
-
Kaldalón hf.: Routine Announcement Regarding Share Buybacks Pursuant to Buyback Program
-
Aicuris Presents Positive Phase 2 Results for Pritelivir and Favorable Phase 1 Safety Data for AIC468 at ID Week 2025
-
Form 8.3 - Unite Group plc
-
Prepayments (CK93) - Totalkredit A/S
-
Prepayments (CK93) - Nykredit Realkredit A/S
-
Festi hf.: Buyback program week 42
-
Angelini Ventures Deepens Commitment to CoMind, a Neurotech Redefining Brain Monitoring, with Participation in $60 Million Round Bringing Total Funding to $102.5 Million
-
Eimskip: Transaction in relation to a share buy-back program
-
Patient-Reported Outcomes from VERITAC-2 Clinical Trial Support Clinical Benefit of Vepdegestrant in Patients with ESR1-Mutated, ER+/HER2- Advanced or Metastatic Breast Cancer Previously Treated with
-
Data on debtor composition
-
Coloplast A/S - FY 2024/25 Earnings Release - Invitation for conference call on 4 Nov 2025 at 11.00 CET
-
Danske Bank share buy-back programme: transactions in week 42
-
Entrepreneurs stay the course: 92% would choose this path again
-
Perspective Therapeutics Presents Updated Interim Data from its Ongoing Phase 1/2a Clinical Trial of [212Pb]VMT-α-NET at the ESMO Congress 2025
-
Niu Technologies to Report Third Quarter 2025 Financial Results on November 17, 2025
-
ImmunOs Therapeutics Reports Promising Clinical Activity of IOS-1002 in Advanced Solid Tumors
-
Prepayments, Realkredit Danmark A/S
-
CoinEx Reinforces Transparency with Updated Proof of Reserve – October 2025
-
Alm. Brand A/S – Weekly report on share buybacks
-
Net Asset Value(s)
-
Share buyback programme - week 42
-
Preliminary data on early redemptions (prepayments)
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DALATA HOTEL GROUP PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - GREENCORE GROUP PLC - Ordinary Shares
-
Columbus – Weekly report on share buyback
-
NORBIT - Awarded NOK 120 million order
-
Aspocomp will publish its January-September Interim Report 2025 on Thursday, October 30, 2025
-
Municipality Finance issues SEK 1 billion tap under its MTN programme
-
Municipality Finance issues a EUR 50 million tap under its MTN programme
-
Medela AG Introduces the New Motion InBra™ Wearable Breast Pump – Where Dependable Performance Meets Everyday Comfort
-
PRESS RELEASE: CMB.TECH NV announces fixed income investor meetings
-
PRESS RELEASE: CMB.TECH trading update
-
Debtor distribution data (CK92) - Totalkredit A/S
-
Debtor distribution data (CK92) - Nykredit Realkredit A/S
